[1]
|
M. Schabet, “Epidemiology of Primary CNS Lymphoma,” Journal of Neuro-Oncology, Vol. 43, No. 3, 1999, pp. 199-201. doi:10.1023/A:1006290032052
|
[2]
|
CBTRUS, “Statistical Report: Primary Brain Tumors in the United States, 1992-1997,” Central Brain Tumor Registry of the United States, Chicago, 2000.
|
[3]
|
T. N. Shenkier, J. Y. Blay, B. P. O’Neill, et al., “Primary CNS Lymphoma of T-Cell Origin: A Descriptive Analysis from the International Primary CNS Lymphoma Collaborative Group,” Journal of Clinical Oncology, Vol. 23, No. 10, 2005, pp. 2233-2239.
doi:10.1200/JCO.2005.07.109
|
[4]
|
M. S. Dulai, C. Y. Park, W. D. Howell, et al., “CNS T-Cell Lymphoma: An Under Recognised Entity?” Acta Neuropathologica, Vol. 115, No. 3, 2008, pp. 345-356.
doi:10.1007/s00401-007-0338-y
|
[5]
|
A. J. Ferreri, M. Reni, F. Pasini, et al., “A Multicenter Study of Treatment of Primary CNS Lymphoma,” Neurology, Vol. 58, No. 10, 2002, pp. 1513-1520.
doi:10.1212/WNL.58.10.1513
|
[6]
|
A. Ferreri, L. Abrey, J. Y. Blay, et al., “Summary Statement on Primary Central Nervous System Lymphomas from the Eighth International Conference on Malignant Lymphoma: Special Article,” Journal of Clinical Oncology, Vol. 21, No. 12, 2003, pp. 2407-2414.
doi:10.1200/JCO.2003.01.135
|
[7]
|
A. J. Ferreri, J. Y. Blay, M. Reni, et al., “Prognostic Scoring System for Primary CNS Lymphomas: The International Extranodal Lymphoma Study Group Experience,” Journal of Clinical Oncology, Vol. 21, No. 2, 2003, pp. 266-272. doi:10.1200/JCO.2003.09.139
|
[8]
|
N. Hayabuchi, Y. Shibamoto and Y. Onizuka, “Primary Central Nervous System Lymphoma in Japan: A Nationwide Survey,” International Journal of Radiation Oncology * Biology * Physics, Vol. 44, No. 2, 1999, pp. 265-272. doi:10.1016/S0360-3016(98)00564-1
|
[9]
|
T. R. Cote, A. Manns, C. R. Hardy, F. J. Yellin, P. Hartge, AIDS/Cancer Study Group, “Epidemiology of Brain Lymphoma among People with or without Immunodeficiency Syndrome,” Journal of the National Cancer Institute, Vol. 88, No. 10, 1996, pp. 675-679.
doi:10.1093/jnci/88.10.675
|
[10]
|
C. Sarkar, M. Sharma, P. Deb, et al., “Primary Central Nervous System Lymphoma-A Hospital Based Study of Incidence and Clinicopathological Features from India (1980-2003),” Journal of Neuro-Oncology, Vol. 71, No. 2, 2005, pp. 199-204. doi:10.1007/s11060-004-1385-z
|
[11]
|
M. Takeshita, O. Kubo, Y. Tajika, et al., “Primary Central Nervous System T-Cell Lymphoma-Case Report,” Neurologia Medico-Chirurgica (Tokyo), Vol. 39, No. 6, 1999, pp. 452-458. doi:10.2176/nmc.39.452
|
[12]
|
E. Villegas, S. Villa, A. Lopez-Guillermo, et al., “Primary Central Nervous System Lymphoma of T-Cell Origin: Description of Two Cases and Review of the Literature,” Journal of Neuro-Oncology, Vol. 34, No. 2, 1997, pp. 157-161. doi:10.1023/A:1005754212792
|
[13]
|
F. Hochberg and D. Miller, “Primary Central Nervous System Lymphoma,” Journal of Neurosurgery, Vol. 68, No. 6, 1988, pp. 835-853. doi:10.3171/jns.1988.68.6.0835
|
[14]
|
T. L. Helle, R. H. Britt and T. V. Colby, “Primary Lymphoma of the Central Nervous System: Clinicopathological Study of Experience at Stanford,” Journal of Neurosurgery, Vol. 60, No. 1, 1984, pp. 94-103.
doi:10.3171/jns.1984.60.1.0094
|
[15]
|
E. Y. Kim and S. S. Kim, “Magnetic Resonance Findings of Primary Central Nervous System T-Cell Lymphoma in Immunocompetent Patients,” Acta Radiologica, Vol. 46, No. 2, 2005, pp. 187-192.
doi:10.1080/02841850510022714
|
[16]
|
A. Harder, C. Dudel, I. Anagnostopoulos, et al., “Molecular Genetic Diagnosis of a Primary Central Nervous System T Cell Lymphoma,” Acta Radiologica, Vol. 105, No. 1, 2003, pp. 65-68.
|
[17]
|
L. M. Deangelis, W. Seiferheld, S. C. Schold, et al., “Combination Chemotherapy and Radiotherapy for Primary Central Nervous System Lymphoma. Radiation Therapy Oncology Group Study 93-10,” Journal of Clinical Oncology, Vol. 20, No. 24, 2002, pp. 4643-4648.
doi:10.1200/JCO.2002.11.013
|